nodes	percent_of_prediction	percent_of_DWPC	metapath
Penbutolol—ORM1—Vemurafenib—melanoma	0.856	1	CbGbCtD
Penbutolol—Colitis ischaemic—Docetaxel—melanoma	0.00324	0.0697	CcSEcCtD
Penbutolol—Disorientation—Bleomycin—melanoma	0.00138	0.0296	CcSEcCtD
Penbutolol—Throat sore—Docetaxel—melanoma	0.00132	0.0284	CcSEcCtD
Penbutolol—Oropharyngeal discomfort—Docetaxel—melanoma	0.00131	0.0281	CcSEcCtD
Penbutolol—Rash erythematous—Docetaxel—melanoma	0.00124	0.0267	CcSEcCtD
Penbutolol—Alopecia—Vemurafenib—melanoma	0.00124	0.0267	CcSEcCtD
Penbutolol—Amnesia—Carmustine—melanoma	0.00114	0.0246	CcSEcCtD
Penbutolol—Amnesia—Temozolomide—melanoma	0.0011	0.0238	CcSEcCtD
Penbutolol—Cough—Vemurafenib—melanoma	0.00107	0.023	CcSEcCtD
Penbutolol—Oropharyngeal pain—Docetaxel—melanoma	0.00105	0.0225	CcSEcCtD
Penbutolol—Affect lability—Temozolomide—melanoma	0.00102	0.022	CcSEcCtD
Penbutolol—Mood swings—Temozolomide—melanoma	0.000983	0.0212	CcSEcCtD
Penbutolol—Fatigue—Vemurafenib—melanoma	0.000861	0.0185	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Temozolomide—melanoma	0.000834	0.018	CcSEcCtD
Penbutolol—Erectile dysfunction—Temozolomide—melanoma	0.000826	0.0178	CcSEcCtD
Penbutolol—Depression—Carmustine—melanoma	0.000825	0.0178	CcSEcCtD
Penbutolol—Agranulocytosis—Dactinomycin—melanoma	0.000825	0.0178	CcSEcCtD
Penbutolol—Depression—Temozolomide—melanoma	0.000798	0.0172	CcSEcCtD
Penbutolol—Body temperature increased—Vemurafenib—melanoma	0.000789	0.017	CcSEcCtD
Penbutolol—Alopecia—Bleomycin—melanoma	0.000752	0.0162	CcSEcCtD
Penbutolol—Asthenia—Vemurafenib—melanoma	0.000716	0.0154	CcSEcCtD
Penbutolol—Alopecia—Dactinomycin—melanoma	0.000702	0.0151	CcSEcCtD
Penbutolol—Diarrhoea—Vemurafenib—melanoma	0.000683	0.0147	CcSEcCtD
Penbutolol—Dizziness—Vemurafenib—melanoma	0.00066	0.0142	CcSEcCtD
Penbutolol—Alopecia—Carmustine—melanoma	0.000657	0.0141	CcSEcCtD
Penbutolol—Cough—Bleomycin—melanoma	0.000647	0.0139	CcSEcCtD
Penbutolol—Alopecia—Temozolomide—melanoma	0.000635	0.0137	CcSEcCtD
Penbutolol—Headache—Vemurafenib—melanoma	0.000625	0.0135	CcSEcCtD
Penbutolol—Nausea—Vemurafenib—melanoma	0.000593	0.0128	CcSEcCtD
Penbutolol—Cough—Temozolomide—melanoma	0.000546	0.0117	CcSEcCtD
Penbutolol—Dyspnoea—Bleomycin—melanoma	0.000539	0.0116	CcSEcCtD
Penbutolol—Pain—Bleomycin—melanoma	0.000517	0.0111	CcSEcCtD
Penbutolol—Agranulocytosis—Docetaxel—melanoma	0.000496	0.0107	CcSEcCtD
Penbutolol—Hyperhidrosis—Temozolomide—melanoma	0.000493	0.0106	CcSEcCtD
Penbutolol—Fatigue—Dactinomycin—melanoma	0.000486	0.0105	CcSEcCtD
Penbutolol—Pain—Dactinomycin—melanoma	0.000482	0.0104	CcSEcCtD
Penbutolol—Body temperature increased—Bleomycin—melanoma	0.000478	0.0103	CcSEcCtD
Penbutolol—Insomnia—Carmustine—melanoma	0.000478	0.0103	CcSEcCtD
Penbutolol—Dyspnoea—Carmustine—melanoma	0.000471	0.0101	CcSEcCtD
Penbutolol—Insomnia—Temozolomide—melanoma	0.000461	0.00993	CcSEcCtD
Penbutolol—Dyspnoea—Temozolomide—melanoma	0.000455	0.00979	CcSEcCtD
Penbutolol—Pain—Carmustine—melanoma	0.000451	0.00972	CcSEcCtD
Penbutolol—Dyspepsia—Temozolomide—melanoma	0.000449	0.00967	CcSEcCtD
Penbutolol—Body temperature increased—Dactinomycin—melanoma	0.000446	0.0096	CcSEcCtD
Penbutolol—Fatigue—Temozolomide—melanoma	0.00044	0.00947	CcSEcCtD
Penbutolol—Pain—Temozolomide—melanoma	0.000436	0.00939	CcSEcCtD
Penbutolol—Asthenia—Bleomycin—melanoma	0.000434	0.00934	CcSEcCtD
Penbutolol—Alopecia—Docetaxel—melanoma	0.000422	0.00908	CcSEcCtD
Penbutolol—Body temperature increased—Carmustine—melanoma	0.000417	0.00898	CcSEcCtD
Penbutolol—Asthenia—Dactinomycin—melanoma	0.000405	0.00871	CcSEcCtD
Penbutolol—Body temperature increased—Temozolomide—melanoma	0.000403	0.00868	CcSEcCtD
Penbutolol—Timolol—ABCB1—melanoma	0.000395	0.484	CrCbGaD
Penbutolol—Diarrhoea—Dactinomycin—melanoma	0.000386	0.00831	CcSEcCtD
Penbutolol—Asthenia—Carmustine—melanoma	0.000379	0.00815	CcSEcCtD
Penbutolol—Asthenia—Temozolomide—melanoma	0.000366	0.00788	CcSEcCtD
Penbutolol—Cough—Docetaxel—melanoma	0.000363	0.00781	CcSEcCtD
Penbutolol—Diarrhoea—Carmustine—melanoma	0.000361	0.00778	CcSEcCtD
Penbutolol—Nausea—Bleomycin—melanoma	0.000359	0.00773	CcSEcCtD
Penbutolol—Dizziness—Carmustine—melanoma	0.000349	0.00752	CcSEcCtD
Penbutolol—Diarrhoea—Temozolomide—melanoma	0.000349	0.00751	CcSEcCtD
Penbutolol—Dizziness—Temozolomide—melanoma	0.000337	0.00726	CcSEcCtD
Penbutolol—Nausea—Dactinomycin—melanoma	0.000335	0.00721	CcSEcCtD
Penbutolol—Headache—Carmustine—melanoma	0.000331	0.00712	CcSEcCtD
Penbutolol—Headache—Temozolomide—melanoma	0.00032	0.00688	CcSEcCtD
Penbutolol—Nadolol—ABCB1—melanoma	0.000314	0.384	CrCbGaD
Penbutolol—Nausea—Carmustine—melanoma	0.000314	0.00675	CcSEcCtD
Penbutolol—Insomnia—Docetaxel—melanoma	0.000307	0.00661	CcSEcCtD
Penbutolol—Nausea—Temozolomide—melanoma	0.000303	0.00652	CcSEcCtD
Penbutolol—Dyspnoea—Docetaxel—melanoma	0.000303	0.00651	CcSEcCtD
Penbutolol—Dyspepsia—Docetaxel—melanoma	0.000299	0.00643	CcSEcCtD
Penbutolol—Fatigue—Docetaxel—melanoma	0.000293	0.0063	CcSEcCtD
Penbutolol—Pain—Docetaxel—melanoma	0.00029	0.00625	CcSEcCtD
Penbutolol—Body temperature increased—Docetaxel—melanoma	0.000268	0.00577	CcSEcCtD
Penbutolol—Asthenia—Docetaxel—melanoma	0.000243	0.00524	CcSEcCtD
Penbutolol—Diarrhoea—Docetaxel—melanoma	0.000232	0.005	CcSEcCtD
Penbutolol—Dizziness—Docetaxel—melanoma	0.000224	0.00483	CcSEcCtD
Penbutolol—Headache—Docetaxel—melanoma	0.000213	0.00458	CcSEcCtD
Penbutolol—Nausea—Docetaxel—melanoma	0.000202	0.00434	CcSEcCtD
Penbutolol—Propranolol—ABCB1—melanoma	0.000108	0.132	CrCbGaD
Penbutolol—ADRB2—Signaling Pathways—CD86—melanoma	2.67e-05	0.000275	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—CXCL8—melanoma	2.66e-05	0.000274	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—EDN1—melanoma	2.64e-05	0.000272	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CSF2—melanoma	2.64e-05	0.000272	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—FGF1—melanoma	2.64e-05	0.000272	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CD86—melanoma	2.61e-05	0.000269	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—CXCL8—melanoma	2.6e-05	0.000268	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—FN1—melanoma	2.6e-05	0.000268	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—IL2—melanoma	2.6e-05	0.000268	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—EDN1—melanoma	2.59e-05	0.000266	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—E2F1—melanoma	2.59e-05	0.000266	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—FGF1—melanoma	2.58e-05	0.000266	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CSF2—melanoma	2.58e-05	0.000266	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—PIK3CB—melanoma	2.57e-05	0.000265	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PDGFRA—melanoma	2.56e-05	0.000264	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—NOTCH1—melanoma	2.55e-05	0.000262	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—IL2—melanoma	2.55e-05	0.000262	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PRKCA—melanoma	2.53e-05	0.000261	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—ITGB3—melanoma	2.53e-05	0.000261	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—E2F1—melanoma	2.53e-05	0.000261	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CSF2—melanoma	2.53e-05	0.00026	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—FGF1—melanoma	2.53e-05	0.00026	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—PIK3CB—melanoma	2.52e-05	0.000259	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PDGFRA—melanoma	2.5e-05	0.000258	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CD80—melanoma	2.5e-05	0.000257	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PIK3CG—melanoma	2.49e-05	0.000257	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—KIT—melanoma	2.49e-05	0.000257	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—APC—melanoma	2.49e-05	0.000257	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—NRAS—melanoma	2.49e-05	0.000257	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—IL2—melanoma	2.49e-05	0.000256	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—SPP1—melanoma	2.48e-05	0.000256	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PRKCA—melanoma	2.48e-05	0.000255	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—ITGB3—melanoma	2.48e-05	0.000255	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—MAP2K2—melanoma	2.48e-05	0.000255	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—CXCL8—melanoma	2.47e-05	0.000255	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—E2F1—melanoma	2.47e-05	0.000255	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—EGF—melanoma	2.46e-05	0.000254	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—PIK3CB—melanoma	2.46e-05	0.000254	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PDGFRA—melanoma	2.45e-05	0.000252	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—SPP1—melanoma	2.43e-05	0.00025	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PRKCA—melanoma	2.42e-05	0.00025	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—ITGB3—melanoma	2.42e-05	0.00025	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—MAP2K2—melanoma	2.42e-05	0.00025	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—CXCL8—melanoma	2.42e-05	0.000249	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—MAPK3—melanoma	2.39e-05	0.000246	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—SPP1—melanoma	2.38e-05	0.000245	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—MAP2K2—melanoma	2.37e-05	0.000244	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—CXCL8—melanoma	2.37e-05	0.000244	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—IL2—melanoma	2.36e-05	0.000244	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—TERT—melanoma	2.35e-05	0.000243	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—RAC1—melanoma	2.35e-05	0.000242	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—BRAF—melanoma	2.34e-05	0.000241	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—IL2—melanoma	2.31e-05	0.000238	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—TERT—melanoma	2.3e-05	0.000237	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—RAC1—melanoma	2.3e-05	0.000237	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—IGF1—melanoma	2.28e-05	0.000235	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—MAPK1—melanoma	2.27e-05	0.000234	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—EGFR—melanoma	2.27e-05	0.000234	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—IL2—melanoma	2.26e-05	0.000233	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—TERT—melanoma	2.25e-05	0.000232	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—HIF1A—melanoma	2.25e-05	0.000232	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—RAC1—melanoma	2.25e-05	0.000231	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—MAP2K1—melanoma	2.2e-05	0.000227	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—HIF1A—melanoma	2.2e-05	0.000227	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PIK3CD—melanoma	2.19e-05	0.000226	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—PIK3CA—melanoma	2.17e-05	0.000224	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—HIF1A—melanoma	2.15e-05	0.000222	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—KDR—melanoma	2.15e-05	0.000222	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—KRAS—melanoma	2.14e-05	0.000221	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—KDR—melanoma	2.11e-05	0.000217	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—FGF2—melanoma	2.1e-05	0.000216	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—FN1—melanoma	2.07e-05	0.000214	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—KDR—melanoma	2.06e-05	0.000212	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—NOTCH1—melanoma	2.03e-05	0.000209	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—FN1—melanoma	2.03e-05	0.000209	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CD80—melanoma	1.99e-05	0.000205	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—NOTCH1—melanoma	1.98e-05	0.000204	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—APC—melanoma	1.98e-05	0.000204	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PIK3CG—melanoma	1.98e-05	0.000204	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—KIT—melanoma	1.98e-05	0.000204	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—NRAS—melanoma	1.98e-05	0.000204	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—FN1—melanoma	1.98e-05	0.000204	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—PIK3CA—melanoma	1.97e-05	0.000203	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—MDM2—melanoma	1.96e-05	0.000202	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—EGF—melanoma	1.96e-05	0.000202	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CD80—melanoma	1.94e-05	0.0002	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—APC—melanoma	1.94e-05	0.0002	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—KIT—melanoma	1.94e-05	0.0002	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PIK3CG—melanoma	1.94e-05	0.0002	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—NRAS—melanoma	1.94e-05	0.0002	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—NOTCH1—melanoma	1.94e-05	0.0002	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—ERBB2—melanoma	1.93e-05	0.000199	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—EGF—melanoma	1.92e-05	0.000198	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PIK3CB—melanoma	1.91e-05	0.000197	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CD80—melanoma	1.9e-05	0.000196	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—MAPK3—melanoma	1.9e-05	0.000196	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—KIT—melanoma	1.9e-05	0.000196	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—APC—melanoma	1.9e-05	0.000196	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PIK3CG—melanoma	1.9e-05	0.000196	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—NRAS—melanoma	1.9e-05	0.000196	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—EGF—melanoma	1.88e-05	0.000193	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—BRAF—melanoma	1.86e-05	0.000192	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—MAPK3—melanoma	1.86e-05	0.000192	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CXCL8—melanoma	1.83e-05	0.000189	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—BRAF—melanoma	1.82e-05	0.000188	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—HRAS—melanoma	1.82e-05	0.000188	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—MAPK3—melanoma	1.82e-05	0.000187	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IGF1—melanoma	1.82e-05	0.000187	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—MAPK1—melanoma	1.81e-05	0.000186	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—EGFR—melanoma	1.81e-05	0.000186	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CDKN1B—melanoma	1.79e-05	0.000185	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—BRAF—melanoma	1.78e-05	0.000184	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IGF1—melanoma	1.78e-05	0.000183	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—AKT1—melanoma	1.77e-05	0.000183	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—MAPK1—melanoma	1.77e-05	0.000182	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—EGFR—melanoma	1.77e-05	0.000182	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CASP3—melanoma	1.76e-05	0.000181	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—MAP2K1—melanoma	1.76e-05	0.000181	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—IL2—melanoma	1.75e-05	0.000181	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—IL6—melanoma	1.74e-05	0.00018	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PIK3CD—melanoma	1.74e-05	0.00018	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IGF1—melanoma	1.74e-05	0.000179	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—MAPK1—melanoma	1.73e-05	0.000178	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—EGFR—melanoma	1.73e-05	0.000178	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—PIK3CA—melanoma	1.73e-05	0.000178	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—MAP2K1—melanoma	1.72e-05	0.000177	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CCND1—melanoma	1.71e-05	0.000176	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—KRAS—melanoma	1.71e-05	0.000176	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PIK3CD—melanoma	1.71e-05	0.000176	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CTNNB1—melanoma	1.69e-05	0.000174	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—PIK3CA—melanoma	1.69e-05	0.000174	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—MAP2K1—melanoma	1.68e-05	0.000173	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—KRAS—melanoma	1.67e-05	0.000172	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—FGF2—melanoma	1.67e-05	0.000172	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PIK3CD—melanoma	1.67e-05	0.000172	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—MMP9—melanoma	1.66e-05	0.000171	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CDKN1A—melanoma	1.65e-05	0.00017	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—PIK3CA—melanoma	1.65e-05	0.00017	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PTEN—melanoma	1.65e-05	0.00017	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—NFKB1—melanoma	1.64e-05	0.000169	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—FGF2—melanoma	1.63e-05	0.000168	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—KRAS—melanoma	1.63e-05	0.000168	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—AKT1—melanoma	1.61e-05	0.000166	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—FGF2—melanoma	1.6e-05	0.000165	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—PIK3CA—melanoma	1.57e-05	0.000162	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—MDM2—melanoma	1.56e-05	0.000161	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—ERBB2—melanoma	1.54e-05	0.000159	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—PIK3CA—melanoma	1.53e-05	0.000158	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—MDM2—melanoma	1.53e-05	0.000157	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PIK3CB—melanoma	1.52e-05	0.000157	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—ERBB2—melanoma	1.51e-05	0.000155	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—PIK3CA—melanoma	1.5e-05	0.000155	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—MDM2—melanoma	1.49e-05	0.000154	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—VEGFA—melanoma	1.49e-05	0.000154	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PIK3CB—melanoma	1.49e-05	0.000153	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—STAT3—melanoma	1.48e-05	0.000152	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—ERBB2—melanoma	1.47e-05	0.000152	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—NRAS—melanoma	1.47e-05	0.000152	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CXCL8—melanoma	1.46e-05	0.000151	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PIK3CB—melanoma	1.45e-05	0.00015	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—HRAS—melanoma	1.45e-05	0.00015	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CXCL8—melanoma	1.43e-05	0.000147	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CDKN1B—melanoma	1.43e-05	0.000147	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—HRAS—melanoma	1.42e-05	0.000146	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—AKT1—melanoma	1.41e-05	0.000145	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—MAPK3—melanoma	1.41e-05	0.000145	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CASP3—melanoma	1.4e-05	0.000144	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CXCL8—melanoma	1.4e-05	0.000144	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IL2—melanoma	1.4e-05	0.000144	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CDKN1B—melanoma	1.4e-05	0.000144	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—IL6—melanoma	1.39e-05	0.000143	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—HRAS—melanoma	1.39e-05	0.000143	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—AKT1—melanoma	1.38e-05	0.000142	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—MYC—melanoma	1.37e-05	0.000141	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CASP3—melanoma	1.37e-05	0.000141	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IL2—melanoma	1.37e-05	0.000141	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CDKN1B—melanoma	1.36e-05	0.000141	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CCND1—melanoma	1.36e-05	0.00014	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—IL6—melanoma	1.36e-05	0.00014	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—AKT1—melanoma	1.35e-05	0.000139	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CTNNB1—melanoma	1.35e-05	0.000139	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—MAPK1—melanoma	1.34e-05	0.000138	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—EGFR—melanoma	1.34e-05	0.000138	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CASP3—melanoma	1.34e-05	0.000138	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IL2—melanoma	1.34e-05	0.000138	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CCND1—melanoma	1.33e-05	0.000137	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—IL6—melanoma	1.33e-05	0.000137	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—MMP9—melanoma	1.32e-05	0.000136	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CTNNB1—melanoma	1.32e-05	0.000136	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CDKN1A—melanoma	1.32e-05	0.000136	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PTEN—melanoma	1.31e-05	0.000135	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—NFKB1—melanoma	1.31e-05	0.000135	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CCND1—melanoma	1.3e-05	0.000134	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—MMP9—melanoma	1.29e-05	0.000133	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CTNNB1—melanoma	1.29e-05	0.000133	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CDKN1A—melanoma	1.29e-05	0.000133	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PTEN—melanoma	1.28e-05	0.000132	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—AKT1—melanoma	1.28e-05	0.000132	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—NFKB1—melanoma	1.28e-05	0.000132	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—KRAS—melanoma	1.27e-05	0.000131	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—MMP9—melanoma	1.26e-05	0.00013	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CDKN1A—melanoma	1.26e-05	0.00013	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PTEN—melanoma	1.26e-05	0.000129	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—AKT1—melanoma	1.25e-05	0.000129	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—NFKB1—melanoma	1.25e-05	0.000129	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—AKT1—melanoma	1.23e-05	0.000126	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—VEGFA—melanoma	1.19e-05	0.000122	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—STAT3—melanoma	1.17e-05	0.000121	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—NRAS—melanoma	1.17e-05	0.000121	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PIK3CA—melanoma	1.16e-05	0.00012	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—VEGFA—melanoma	1.16e-05	0.00012	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—STAT3—melanoma	1.15e-05	0.000118	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—NRAS—melanoma	1.15e-05	0.000118	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—VEGFA—melanoma	1.13e-05	0.000117	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—TP53—melanoma	1.13e-05	0.000116	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—STAT3—melanoma	1.12e-05	0.000116	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—MAPK3—melanoma	1.12e-05	0.000116	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—NRAS—melanoma	1.12e-05	0.000116	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—MAPK3—melanoma	1.1e-05	0.000113	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—MYC—melanoma	1.09e-05	0.000112	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—HRAS—melanoma	1.08e-05	0.000111	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—MAPK3—melanoma	1.07e-05	0.000111	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—MAPK1—melanoma	1.07e-05	0.00011	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—MYC—melanoma	1.07e-05	0.00011	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—EGFR—melanoma	1.07e-05	0.00011	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—MAPK1—melanoma	1.04e-05	0.000108	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—EGFR—melanoma	1.04e-05	0.000108	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—MYC—melanoma	1.04e-05	0.000108	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—IL6—melanoma	1.03e-05	0.000106	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—MAPK1—melanoma	1.02e-05	0.000105	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—EGFR—melanoma	1.02e-05	0.000105	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—KRAS—melanoma	1.01e-05	0.000104	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—KRAS—melanoma	9.87e-06	0.000102	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—KRAS—melanoma	9.65e-06	9.94e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—AKT1—melanoma	9.51e-06	9.79e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PIK3CA—melanoma	9.27e-06	9.55e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PIK3CA—melanoma	9.07e-06	9.34e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—TP53—melanoma	8.96e-06	9.24e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PIK3CA—melanoma	8.86e-06	9.13e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—TP53—melanoma	8.77e-06	9.04e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—TP53—melanoma	8.58e-06	8.84e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—HRAS—melanoma	8.57e-06	8.83e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—HRAS—melanoma	8.39e-06	8.64e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IL6—melanoma	8.21e-06	8.46e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—HRAS—melanoma	8.2e-06	8.45e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IL6—melanoma	8.03e-06	8.27e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IL6—melanoma	7.85e-06	8.09e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—AKT1—melanoma	7.57e-06	7.8e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—AKT1—melanoma	7.41e-06	7.63e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—AKT1—melanoma	7.24e-06	7.46e-05	CbGpPWpGaD
